baber/WOPTO huggingface dataset:
Patent MX-2010002234-A (MX)
Title: Power dampener for a fault current limiter.
Inventor: DARMANN FRANCIS ANTHONY
IPC: H02H9/00
Filed: 2007-08-30
Abstract: A method of dampening a transient in a DC biasing coil in a fault current limiter, the method including the step of: interconnecting a transient suppression circuit across the DC biasing coil, the transient suppression circuit being operative when the transient voltage across the DC biasing coil exceeds a predetermined maximum.
Patent MX-2010002920-A (MX)
Title: Handle for heat shrink packages.
Inventor: CERF ALAIN
IPC: B65D71/28
Filed: 2008-09-15
Abstract: The objective of this invention is to provide a handle for carrying an article or a bundle of bottles that is more resistant to tearing and delaminating and has the ability to carry heavy loads. This is accomplished by placing a strip on the inside of the wrapping material and wrapping an article, so that the strip that forms the handle is enclosed within the wrapping material. By placing the handle inside the wrapping material so that the strip overlaps when the wrapping material covers the article, the handle is capable of carrying heavy loads.
Patent MX-2010004857-A (MX)
Title: Benzodiazepinone compounds useful in the treatment of skin conditions.
Inventor: GLICK GARY D
IPC: C07D243/18
Filed: 2008-11-06
Abstract: The present invention provides a family of benzodiazepinone compounds and pharmaceutical compositions thereof. The present invention also provides methods of treating certain skin conditions, e.g., atopic dermatitis, rosacea, or psoriasis, by administering a benzodiazepinone and methods of reducing the proliferation of keratinocyte cells by exposing such cells to a benzodiazepinone.
Patent MX-2010005271-A (MX)
Title: Adjustable tissue support member.
Inventor: EVANS DOUG
IPC: A61F2/00
Filed: 2008-11-13
Abstract: The present disclosure relates to implants having two arms and a support portion configured to support a body tissue, such as a urethra. The implants are anchored in soft tissue with tissue anchors having a plurality of barbs. The tissue anchors contain an aperture through which a portion of arm is maintained. A locking member is disposed within at least one of the arms to facilitate fixation of the arm to at least one of the anchors.
Patent MX-2010007724-A (MX)
Title: 'o' head design.
Inventor: GUTIERREZ JOSE RAMON
IPC: F04D29/66
Filed: 2009-01-14
Abstract: A discharge head features a motor mounting plate configured for mounting on a motor; a base plate configured for mounting on a pump assembly; an elbow transition mounted on the base plate configured for providing discharge from the pump assembly; a seal housing pipe coupled to the elbow transition configured for receiving a mechanical seal or packing arrangement; supporting pipes arranged between the motor mounting plate and the base plate; and ribs arranged between the supporting pipes and the seal housing pipe configured to prevent substantially lateral and torsional movement, including movement due to reacting hydraulic forces at a pump nozzle and inertia from a driver. The discharge head according to the present invention makes it quicker and easier to couple together the shaft of a pump and the shaft of a motor in such VTSH pumps when compared to the techniques known in the art.
Patent MX-2010007867-A (MX)
Title: Concentrated personal cleansing compositions.
Inventor: HUTCHINS THOMAS ALLEN
IPC: A61K8/46
Filed: 2009-01-16
Abstract: The present invention relates to concentrated personal cleansing compositions having desirable lathering and dissolution properties.
Patent MX-2010007929-A (MX)
Title: Novel imidazolinylmethyl aryl sulfonamides.
Inventor: O'YANG COUNDE
IPC: A61K31/4174
Filed: 2009-01-26
Abstract: This invention relates to an alpha- 1 A receptor partial agonist, which is represented by Formula (I) and pharmaceutically acceptable salts or solvates thereof. The invention further relates to pharmaceutical compositions containing formula I, methods for their use as therapeutic agents, and methods of preparation thereof.
Patent MX-2010009822-A (MX)
Title: Product resulting from aluminium recycled cans for replacing iron and steel deoxidizers.
Inventor: NAVARRO ARTURO LAZCANO
IPC: B05D5/00
Filed: 2010-09-06
Abstract: Described is a process for obtaining a product from recycled aluminium cans with an undefined geometry that forms a small semi compacted particle of from about 0.9 mm to about 3.6 mm, which upon being added to the liquid steel in the iron and steel processes reacts in a favourable manner as a deoxidizer resulting from recycled aluminium cans. Said process includes the operation of shredding the can in bales with a granulator which generates a small aluminium particle of 96.5% purity in sizes of from about 0.9 mm to about 3.6 mm and which fully replaces the conventional deoxidizers such as the rolled wire of from about 15 mm to about 17 mm of thickness and small shot blasts or billets of different sizes which require to be passed through a step in its manufacturing process of a costly fusion, consequently generating a production cost higher than the inventive product.
Patent MX-2010010326-A (MX)
Title: A system and method for enhanced removal of co2 from a mixed gas stream via use of a catalyst.
Inventor: HANDAGAMA NARESHKUMAR B
IPC: B01D53/18
Filed: 2009-03-19
Abstract: The proposed invention is directed to a solvent based flue gas processing system for removing CO2 from a flue gas stream. A catalyst is provided to increase the efficiency of the solvent in capturing CO2 from the flue gas stream or in regenerating the solvent.
Patent MX-2010010619-A (MX)
Title: Chemokine receptor modulators.
Inventor: WILSON LAWRENCE
IPC: C07D487/02
Filed: 2009-03-30
Abstract: The invention provides compounds of Formula (I) and pharmaceutically acceptable salts, solvates, tautomers, stereoisomers, and/or esters thereof. These compounds, and pharmaceutical composition comprising such compounds are useful treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers.
Patent MX-2010011439-A (MX)
Title: Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives.
Inventor: SZUCS STEPHEN S
IPC: A61P25/28
Filed: 2009-04-20
Abstract: This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula (I) wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.
Patent MX-2010012329-A (MX)
Title: Discharge end liner.
Inventor: MEPHAM ROBERT
IPC: B02C17/22
Filed: 2009-05-26
Abstract: A discharge end liner attachable to a discharge end wall in a grinding mill. The discharge end liner includes a number of pulp lifter elements mountable on the discharge end wall for at least partially defining a number of chambers rotatable in the predetermined direction respectively between a submerged condition and a raised condition. The discharge end liner also includes one or more grate subassemblies positionable on the pulp lifter elements, for at least partially screening the slurry. At least a part of each grate subassembly is located by an outer portion of the pulp lifter element in a predetermined position relative to the discharge end wall. An inner portion of each pulp lifter element defines an obtuse angle between the inner portion and the outer portion, for permitting the retained portion of the slurry to evacuate from each chamber respectively while each chamber is in the raised condition.
Patent MX-2011000124-A (MX)
Title: Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity.
Inventor: MADDAFORD SHAWN
IPC: C07D417/14
Filed: 2009-07-03
Abstract: Disclosed are benzoxazines and benzothiazines of formula (I) wherein Q is O-(CHR<sup>6</sup>)1-3 or S-(CHR<sup>6</sup>)1-3; R<sup>1</sup> and each R<sup>6</sup> is H, optionally substituted [C1-6 alkyl, C1-4alkaryl, C1-4 alkheterocyclyl, C2-9 heterocyclyl, C3-8 cycloalkyl, C1-4 alkcycloalkyl] or - (CR<sup>1A</sup>R<sup>1B</sup>)nNR<sup>1c</sup>R<sup>1D</sup> wherein R<sup>1A</sup>, R<sup>1B</sup>, R<sup>1C</sup>, R<sup>1D</sup> are independently hydrogen, optionally substituted [C1-6 alkyl, C1-4alkaryl, C1-4 alkheterocyclyl, C2-9 heterocyclyl, C3-8 cycloalkyl, etc.] or wherein R<sup>1A</sup> and R<sup>1B</sup> combine to form =O, or wherein R<sup>1C</sup> and R<sup>1D</sup> combine to form an optionally substituted C2-9 heterocyclyl, and n is an integer between 1-6; each of R<sup>2</sup> and R<sup>3</sup> is H, hal, optionally substituted [C1-6 alkyl, C6-10aryl, C1-6alkaiyl, C2-9 heterocyclyl, C1-6 alkoxy, C1-6 thioalkoxy, (CH2)r2NHC(NH)R2A, CH2)r2NHC(S)NHR<sup>2A</sup>, C1-4 alkheterocyclyl] or hydroxy, wherein r2 is an integer from 0 to 2, R<sup>2A</sup> is optionally substituted [C1-6 alkyl, C6-10aryl, C^alkaryl, C2-9 heterocyclyl, C1-4 alkheterocyclyl,C1-6 thioalkoxy, C1-4 thioalkaryl, aryloyl, C1- 4thioalkheterocylyl, or amino]; each R<sup>4</sup> and R<sup>5</sup> is H, hal, (CH2)r2NHC(NH)R<sup>2A</sup> or CH2)r2NHC(S)NH R<sup>2A</sup>; Y<sup>1</sup> and Y<sup>2</sup> are together =O or Y<sup>1</sup> and Y<sup>2</sup> are independently H, optionally substituted [C1-6 alkyl, C6-10aryl, C1-6alkaryl, C2-9 heterocyclyl, C1-6 alkoxy, C1-6 thioalkoxy, C1-4alkheterocyclyl] or hydroxy; wherein only one of R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> and R<sup>5</sup> is (CH2)r2NHC(NH)R<sup>2A</sup> or CH2)r2NHC(S)NH R<sup>2A</sup>; or a pharmaceutically acceptable salt or prodrug thereof. Said benzoxazines and benzothiazines of formula (I) inhibit nitric oxide synthase (NOS), particularly selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of formula (I), alone or in combinatioon with other pharmaceutically active agents, can be used for treating or preventing various medical conditions.
Patent MX-2011000377-A (MX)
Title: Composition and method to improve the fuel economy of hydrocarbon fueled internal combustion engines.
Inventor: MISSKE ANDREA
IPC: C10L1/14
Filed: 2009-06-16
Abstract: A composition and method of improving the fuel economy of hydrocarbon fuel-powdered internal combustion engines.The composition contains a propoxylated and/or butoxylated reaction product of (a) at least one fatty acid, fatty acid ester, or mixture thereof and (b) a dialkanolamime. I he composition is added to a hydrocarbon fuel in an amount of about 5 to about 2,000 ppm, based on the weight of the hydrocarbon fuel, to reduce friction within the engine and achieve an enhanced fuel economy.
Patent MX-2011000665-A (MX)
Title: System and method for gasification-combustion process using post combustor.
Inventor: ZHANG HANWEI
IPC: F23N5/00
Filed: 2009-07-15
Abstract: Systems and methods for effectively combusting municipal waste are disclosed. Aspects of the present invention provide improved techniques for increasing efficiency of combusting municipal waste as well as decreasing emission of harmful gases. In one aspect of the present invention a system is provided which includes a post combustor (10) for combusting gasified waste. In another aspect of the present invention, a method for using the post combustor (10) to gasify the waste is provided.
Patent MX-2011002628-A (MX)
Title: Piperazine d3 and 5-ht2a receptor modulators.
Inventor: JAESCHKE GEORG
IPC: C07D261/20
Filed: 2009-09-11
Abstract: The present invention relates to compounds of the general formula (I) (I) wherein X, n and R<sup>1</sup> are as described herein, as well as pharmaceutically acceptable salts and esters thereof, as well as their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are dual modulators of the serotonin 5-HT<sub>2a</sub> and dopamine D<sub>3</sub> receptors, useful in the treatment and/or the prevention of cognitive disorders, drug addiction, depression, anxiety, drug dependence, dementias, memory impairment, psychotic disorders comprising schizophrenia, schizoaffective disorders, bipolar disease, mania, psychotic depression, and psychoses comprising paranoia and delusions.
Patent MX-2011003322-A (MX)
Title: Gas generator, method for the production thereof and module having a gas generator.
Inventor: BIERWIRTH SEBASTIAN
IPC: B60R21/264
Filed: 2009-09-29
Abstract: In a gas generator (10), particularly for a protective device in a vehicle, comprising a plurality of parts, a sealant (42) is applied in the region of abutting parts, particularly a sealant (42) that adheres to both abutting parts.
Patent MX-2011003802-A (MX)
Title: Iterative multi-scale method for flow in porous media.
Inventor: JENNY PATRICK
IPC: G06F19/00
Filed: 2009-10-08
Abstract: Computer-implemented iterative multi-scale methods and systems are provided for handling simulation of complex, highly anisotropic, heterogeneous domains. A system and method can be configured to achieve simulation of structures where accurate localization assumptions do not exist. The iterative system and method smoothes the solution field by applying line relaxation in all spatial directions. The smoother is unconditionally stable and leads to sets of tri-diagonal linear systems that can be solved efficiently, such as by the Thomas algorithm. Furthermore, the iterative smoothing procedure, for the improvement of the localization assumptions, does not need to be applied in every time step of the computation.
Patent MX-2011004933-A (MX)
Title: An auto-parameterized tele-controlled static energy converter for cathodic protection systems and a process for producing the same.
Inventor: DELLAMULA DANTE LUIS ALBERINI
IPC: C23F13/22
Filed: 2011-05-10
Abstract: There is provided at least one converter (2) in the structure (1), which is associated with at least one local or remote meter (3) arranged at a local or remote measuring point (4) and in close association with a control module ( 5) that includes at least one processor (6), a means for incorporating and modifying information (7), a means for displaying (8) such information, a database (9) and a program (10) to process the information received. The control module (5) acts on a management means (11) which regulates the passage of continuous current towards the structure (1) to be protected. Converters (2) or adaptive auto-parameterized work autonomously or in association with remote measurement units (3) connected to a control program (10) or a central program (12) located on a remote processor (13) which analyzes the parameters received and calculated and sent to the drives (2), the current values to be managed, being adapted to the performance standards.calculatedmagnitudes.
Patent MX-2011007458-A (MX)
Title: The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer.
Inventor: VENIAMINOVNA CHERNOVSKAYA TATYANA
IPC: A61K38/21
Filed: 2011-07-12
Abstract: The invention is related to the pharmaceutical industry and medicine, in particular, to new PEG-interferon derivatives and the discovery of a new functionally active, highly stable conjugate of interferon to polyethylene glycol with an activity of interferon alpha, with reduced immunogenicity, with prolonged biological effects and improved pharmacokinetic parameters of general formula: (I) where: n - integral values from 227 to 10 000, so that the molecular weight of PEG is about 10 000 - 40 000 Da; m - integer > 4; IFN- natural or recombinant polypeptide having the activity of IFN-alpha. Also, the invention is related to drugs containing the declared conjugate of the formula (I), pharmaceutical compositions containing PEG-IFN conjugate and therapeutically acceptable excipients suitable for treatment of viral infections and cancer, as well as diseases associated with primary or secondary immunodeficiency. The invention is related to the use of conjugate of formula (I) in medicinal products, which have antiviral, antiproliferative and immunomodulatory activity, to approaches for prevention and / or treatment of diseases associated with primary or secondary immunodeficiency that include administration of therapeutically effective amount of conjugate of formula (I), and to the container with such pharmaceutical composition..
Patent MX-2011010776-A (MX)
Title: Copolyether glycol manufacturing process.
Inventor: SUN QUN
IPC: C08G65/30
Filed: 2009-04-15
Abstract: The present invention relates to a continuous process for manufacturing copolyether glycols with high incorporation of alkylene oxide by polymerization of tetrahydrofuran and at least one alkylene oxide in the presence of an acid catalyst, at least one compound containing reactive hydrogen atoms, and a specific diluent or solvent. More particularly, the invention relates to a diluent or solvent-assisted continuous process for manufacturing copolyether glycols with high incorporation of alkylene oxide.
Patent MX-2011012256-A (MX)
Title: Device for controlling gas supply to a burner.
Inventor: GADINI COSTANZO
IPC: F16K31/48
Filed: 2010-05-20
Abstract: A gas supply control device for an apparatus, particularly a coking apparatus, includes timing means (20) and a first command means (12) for manually setting a an opening time interval of a safety valve of a gas tap (1), equipped with a second command means (6). In an installed condition of the control device (10), the command means (6, 12) are operable from outside the structure (7) of the apparatus, with the first command means (12) and the second command means (6) substantially rotating around one same axis, one independent from the other. The timing means (20) of the control device (10) belong to a functional unit (10a) which is coupled or configured for coupling with a portion of the body of the tap (2) which portion, in the above mentioned installed conditions, is located inside the structure (7) of the apparatus. The functional unit (10a) includes switch means (22), controllable by timing means for cutting off the electric current to a solenoid of the tap (1) at the end of a time interval set through the first command means (6), and hence causing the passage of the valve to the respective closed condition.
Patent MX-2011012264-A (MX)
Title: Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists.
Inventor: BUR DANIEL
IPC: C07D277/62
Filed: 2010-05-17
Abstract: The present invention relates to bridged spiro[2.4]heptane derivatives of formula (I), wherein W, Y, Z, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds as ALX receptor and/or FPRL2 agonists for the treatment of inflammatory and obstructive airways diseases.
Patent MX-2011012934-A (MX)
Title: Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians.
Inventor: GUISASOLA JUAN IGNACIO OVEJERO
IPC: A61K39/00
Filed: 2009-12-31
Abstract: The present invention relates to the isolation, purification and characterization of the Lipopolysaccharide (LPS) from Ochrobactrum intermedium strain LMG3306, and their use as immunostimulant of mammalians, the process for the preparation of a pharmaceutical compound for the treatment and/or prevention of the sepsis and adjuvant for a vaccine in immunosupressed animals and against Leishmania.
Patent MX-2012001059-A (MX)
Title: Processes relating to the alkylation of pyrazoles.
Inventor: WANG LINHUA
IPC: C07D409/12
Filed: 2010-07-27
Abstract: The present invention relates to processes for the preparation of a compound of formula (I) comprising reacting a compound of formula (IV) with a compound of formula III or (IIIA) in the presence of an acid; wherein R<sup>1</sup> is C1-C4 haloalkyl; R<sup>2</sup> is optionally substituted alkyl, optionally substituted aryl or optionally substituted heteroaryl; R<sup>3</sup> is methyl or ethyl; R<sup>4</sup> is hydrogen, optionally substituted alkyl, optionally substituted aryl or optionally substituted heteroaryl; and n is 0 or 1.
Patent MX-2012001872-A (MX)
Title: Intravenous formulations of neurokinin-1 antagonists.
Inventor: MONTEITH DAVID
IPC: A61K31/44
Filed: 2010-08-12
Abstract: Pharmaceutical compositions for intravenous administration comprising the compound of Formula I, or pharmaceutically acceptable salts, hydrates or prodrugs thereof are described herein. Methods of preparing the pharmaceutical compositions and methods for treating nausea and/or emesis with the pharmaceutical compositions are also described herein.
Patent MX-2012003572-A (MX)
Title: Chemical production module and dose synthesis card for pet biomarker production system.
Inventor: MCFARLAND AARON
IPC: A61K51/00
Filed: 2010-09-21
Abstract: A microfluidic radiopharmaceutical production system and process for synthesizing per run approximately one (1) to four (4) unit dose of a radiopharmaceutical biomarker for use in positron emission tomography (PET). The system includes a reaction vessel that receives a radioisotope from an accelerator or other radioisotope generator. Organic and aqueous reagents are introduced into the reaction vessel, and the mixture is heated to synthesize a solution of a pre-selected radiopharmaceutical. The radiopharmaceutical solution is passed through a solid phase extraction column and a filter for purification. The synthesis process reduces waste and allows for the production of radiopharmaceutical on an as-needed basis. The synthesis process allows for production on-site and close to the location where the unit dose will be administered to the patient, which reduces time between synthesis and administration, thereby minimizing the loss of active isotopes through decay and allowing the production of lesser amounts of radioisotopes overall.
Patent MX-2012004073-A (MX)
Title: Compact jar for dislodging tools in an oil or gas well.
Inventor: EVANS ROBERT W
IPC: E21B31/107
Filed: 2010-10-08
Abstract: This invention relates to a jar used to dislodge tools stuck in a well. The jar includes two housing portions movable with respect to each other. A release collet forms a portion of one of the housings. A release sleeve is carried by a mandrel and is located within the release collet. After a given amount of movement of the housing with respect to the mandrel, the release mechanism is activated and the two housing sections rapidly move with respect to each other. A hammer portion of the mandrel then strikes an anvil in the anvil housing, thus applying an upward force to the tool lodged in the well.
Patent MX-2012004383-A (MX)
Title: Treating neurotoxicity associated with combinations of 5 - fu or its prodrugs and dpd inhibitors.
Inventor: SPECTOR THOMAS
IPC: A61P35/00
Filed: 2010-10-14
Abstract: Methods for improved administration and dosing of DPD inhibitors in combination with 5-FU and/or 5-FU prodrugs are provided, comprising first administering to a patient in need thereof a DPD inhibitor that substantially eliminates activity of the enzyme in both nervous and non-nervous tissues within the patient and thereafter administering 5-FU or a 5-FU prodrug, wherein the level of 5-FU or 5-FU generated from a prodrug is in substantial excess of DPD inhibitor in the patient.
Patent MX-2012012150-A (MX)
Title: Method for the operation of a wind turbine.
Inventor: BEEKMANN ALFRED
IPC: F03D11/00
Filed: 2011-04-12
Abstract: The invention relates to a method for operating a wind turbine comprising an aerodynamic rotor that has at least one rotor blade. Said method comprises the steps of operating the wind turbine at an operating point that depends on the wind speed, detecting an operating parameter of the operating point, comparing the detected operating parameter with a predetermined reference quantity, and heating the at least one rotor blade when the detected operating parameter exceeds a predetermined variation from the reference quantity, the operation of the wind turbine being continued.